kaymogyn
Kaymogyn GmbH is a Berlin-based German company that develops and distributes the Deumavan brand of medical skin protection and care products for sensitive intimate and anal skin, sold exclusively through German pharmacies and recommended by gynecologists, urologists, dermatologists, midwives, and pharmacists.
- Company typePrivate
- Founded2002
- HeadquartersBerlin, Germany
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What kaymogyn does
Kaymogyn GmbH is a privately-held German medical product company headquartered in Berlin that develops and distributes the Deumavan brand of medical skin protection and care products for sensitive intimate and anal skin. Founded in 2002 by Prof. Dr. Eiko E. Petersen, a gynecologist and microbiologist who developed the formulations from his clinical work at Universitäts-Frauenklinik Freiburg, the company operates a focused four-product portfolio: Schutzsalbe (protective ointment), Vaginalovula (intravaginal ovules for dryness), Waschlotion (soap-free lipid-replenishing cleanser), and Pflegecreme (moisturizing care cream). The core technology consists of lipid-rich paraffin-based formulations combined with active ingredients such as hyaluronic acid, aloe vera, and almond oil, dermatologically tested and developed specifically for the sensitive skin barrier in the intimate area.
The company serves both end consumers and healthcare professionals. End-user segments include women experiencing vaginal dryness (particularly during and after menopause), patients with conditions such as Lichen sclerosus, vulvodynia, atopic dermatitis, or post-cancer therapy discomfort, and men requiring intimate skin protection for conditions like balanitis or post-surgical care. Healthcare professionals (gynecologists, urologists, dermatologists, midwives, pharmacists) function as a referral and recommendation channel, supported by a dedicated HCP portal offering free CME-certified training delivered through the MedCram platform, downloadable product information, and free sample ordering via DocCheck login.
Kaymogyn's business model is B2B2C, monetizing exclusively through pharmacy distribution in Germany, with both stationary local pharmacies and major online mail-order pharmacies (DocMorris, Medpex, Shop-Apotheke, Apodiscounter, Medikamente-per-Klick) as primary sales channels. The company sells directly to HCPs for product familiarization only. No explicit pricing is publicly disclosed; consumers access product pricing only at the pharmacy partner level. Current leadership comprises Managing Directors Mirko Wagner and Alain Cappelle. The company has no disclosed institutional investors, no parent company, and no funding rounds in its history, indicating it has been built and sustained through founder equity and operating cash flow.
kaymogyn firmographics
Firmographics- Name
- kaymogyn
- Legal name
- Kaymogyn GmbH
- Website
- https://deumavan.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Kaymogyn GmbH is a Berlin-based German company that develops and distributes the Deumavan brand of medical skin protection and care products for sensitive intimate and anal skin, sold exclusively through German pharmacies and recommended by gynecologists, urologists, dermatologists, midwives, and pharmacists.
- Ownership category
- akta.pro rank
kaymogyn industry classification
Industry- Product category
- Medical Intimate Care Products
- NAICS
- Toilet Preparation Manufacturing (325620), Soap and Cleaning Compound Manufacturing (32561)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
- akta.pro secondary industries
- Vaginal Moisturizers & Lubricants (CRABAIAI), Sensitive Skin & Barrier Repair (CRABAAAG)
Keywords
Where kaymogyn is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
kaymogyn business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Pharmacy Distribution Sales: Products sold through local pharmacies and online mail-order pharmacies (e.g., DocMorris, Medpex, Shop-Apotheke, Apodiscounter). Consumers purchase in-person or online via pharmacy partners, with Kaymogyn supplying the pharmacy channel.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
kaymogyn product offering
Product offeringCore offering
Kaymogyn develops, manufactures, and distributes medical-grade skin protection and care products under the Deumavan brand, specifically formulated for the sensitive skin of the intimate and anal area. The portfolio comprises four core SKUs: a paraffin-based protective ointment (the Nr. 1 recommendation), moisturizing vaginal ovules for vaginal dryness, a lipid-replenishing soap-free washing lotion, and a moisturizing intimate care cream. All products are dermatologically tested and built on formulations originally developed by founder Prof. Dr. Eiko E. Petersen.
Product overview
Kaymogyn GmbH offers a unified portfolio of medical skin protection and care products under the Deumavan brand, specifically formulated for the sensitive skin in the intimate area. The portfolio consists of four core products: Deumavan Schutzsalbe (Protective Ointment) as the leading recommendation for external intimate and anal skin protection, Deumavan Vaginalovula (Vaginal Ovules) for moistening protection against vaginal dryness, Deumavan Waschlotion (Washing Lotion) as a lipid-replenishing soap-free cleanser, and Deumavan Pflegecreme (Intimate Care Cream) for moisturizing care of sensitive or dry intimate skin. All products are dermatologically tested and developed based on the founder Prof. Dr. Eiko E. Petersen's medical research.
Differentiator
Problem solved
Functional benefit
Brands
- Deumavan: Medical skin protection and care products for sensitive skin in the intimate area, including protective ointment, vaginal ovules, cleansing lotion, and care cream.
Products and services
- Deumavan Schutzsalbe (Protective Ointment) Medical skin protection ointment (Medizinische Hautschutz-Salbe) for the external intimate and anal area. The lead product, formulated with a paraffin-based lipid base to protect and regenerate damaged skin barrier, microtears, and dry intimate skin. Dermatologically tested and developed specifically for the sensitive intimate skin barrier; sold through pharmacies.
- Deumavan Vaginalovula (Vaginal Ovules) Moisturizing protection ovules for vaginal dryness (Befeuchtender Schutz bei Scheidentrockenheit). Intravaginal ovules designed to address atrophic mucosal changes during and after menopause; sold through pharmacies.
- Deumavan Waschlotion (Washing Lotion) Lipid-replenishing and soap-free cleansing lotion (Rückfettende und seifenfreie Waschlotion) for the external intimate and anal area. Supports skin barrier protection without disrupting natural skin flora; sold through pharmacies.
- Deumavan Pflegecreme (Intimate Care Cream) Moisturizing intimate care cream (Feuchtigkeitsspendende Pflege) for sensitive and/or dryness-prone intimate skin. Provides long-lasting hydration and soothing of irritated intimate skin; sold through pharmacies.
Quantifiable outcome
- Deumavan products are recommended by gynecologists, urologists, dermatologists, midwives, and pharmacists across Germany
- +1 more outcomes
Companies that use kaymogyn
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles3 records
kaymogyn technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
kaymogyn partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- MedCramcoreMedCram serves as the online CME course platform hosting Kaymogyn's medical education content. Deumavan's free CME-certified courses covering topics like FGM/C, psychodermatology, phimosis, vulvodynia, and Lichen sclerosus are delivered through the MedCram platform. Medical professionals earn CME points upon completion, automatically transferred to their Landesärztekammer via EFN number. The partnership enables the company to reach healthcare professionals and build product awareness within clinical contexts.
- Atrikom FulfillmentminorAtrikom Fulfillment (Ginsheim-Gustavsburg, Germany) handles the preparation and shipping of sample packages ordered by healthcare professionals through the Deumavan professional portal. Atrikom processes and ships free sample orders on behalf of Kaymogyn.
- DHL (Deutsche Post DHL Group)minorDHL handles shipping and logistics for product returns and complaints (retoure/reklamation). Processes customer address and contact data for return label creation. Acts as an independent data controller for transport services.
- WS Datenschutz GmbHminorWS Datenschutz GmbH (Berlin, Germany) provides external data protection officer services. Melanie Reuter (or Alexander Hönsch in Italian version) serves as the designated Data Protection Officer for Kaymogyn. Contact: [email protected]. Webersohn & Scholtz is the affiliated privacy law firm.
- Meta Platforms (Facebook & Instagram)minorKaymogyn maintains official social media presence on Facebook (https://www.facebook.com/people/Deumavan-Intimpflege/61577819884056/) and Instagram (@deumavan_intimpflege). Meta operates these platforms, and Kaymogyn uses them for brand presence and customer communication. Joint controllership applies under ECJ ruling of 05.06.2018.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
kaymogyn competitors and assessment
Company assessmentDirect peers
- Vagisan: Vagisan (Dr. August Wolff) is Germany's leading intimate care brand for vaginal dryness and intimate skin care — sold through pharmacies with HCP endorsement. It is the most direct competitor to Deumavan, with overlapping product positioning (creams, ovules, moisturizers) and a similar pharmacy-channel GTM motion.
- Multi-Gyn: Multi-Gyn (formerly QP-Products / daréBIOScience European brand) sells intimate care products including vaginal dryness gels and intimate washes through European pharmacies. Directly comparable to Deumavan in feminine intimate care category and pharmacy-led distribution.
- Gynofit: Gynofit (Dr. A. & L. Schmidgall) offers vaginal moisturizers, intimate care gels, and pH-balanced washes sold through Swiss and German pharmacies. Operates in the same intimate care niche as Deumavan with HCP-recommended positioning.
Broad incumbents
- Dr. Wolff Group: Dr. August Wolff GmbH & Co. KG is a German pharmaceutical/cosmetics group whose Vagisan brand competes directly with Deumavan, and whose Linola brand competes in sensitive-skin barrier care. Comparable as a broader dermatology/intimate-care incumbent in the same pharmacy channel.
- Eucerin (Beiersdorf): Eucerin is a leading dermo-cosmetic brand for sensitive and compromised skin. Its barrier-repair product range overlaps with Deumavan's skin protection positioning and is sold in the same pharmacy channel — comparable as a much larger incumbent.
- La Roche-Posay (L'Oréal): La Roche-Posay is a global dermocosmetics leader with sensitive-skin and barrier-repair ranges. Comparable to Deumavan in dermatologically-tested, sensitive-skin positioning and pharmacy distribution, though at vastly greater scale.
- Linola (Dr. Wolff): Linola is Dr. Wolff's skincare brand for dry, sensitive, and compromised skin, sold through German pharmacies. Directly comparable to Deumavan's Schutzsalbe/Pflegecreme barrier protection use cases, though broader in indication scope.
- CeraVe (L'Oréal): CeraVe is a global skincare brand built on ceramide-based barrier repair, available in pharmacies and drugstores. Comparable to Deumavan's sensitive skin and barrier repair positioning with a much broader portfolio and marketing scale.
- Dermapharm Holding SE: Dermapharm is a German pharmaceutical holding with a broad portfolio of branded dermatology and women's health products sold via pharmacies. Comparable to Kaymogyn as a German dermo/gynecology-focused pharma player with pharmacy-channel GTM.
Regional players
- Vagisil (Combe Incorporated): Vagisil is a leading US intimate care brand for itching, dryness, and irritation. Operates in the same intimate-care category as Deumavan but with primary focus on the US market rather than Europe — comparable as a regional player outside Deumavan's DACH core.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights6 records
Customer concentration
kaymogyn social profiles
Digital presencekaymogyn financial estimates
Financial estimateRevenue estimate
Valuation estimate
kaymogyn leadership team
Management profileNumber of profiles
Profiles2 records
kaymogyn funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
kaymogyn M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about kaymogyn
What does kaymogyn do?
Kaymogyn develops, manufactures, and distributes medical-grade skin protection and care products under the Deumavan brand, specifically formulated for the sensitive skin of the intimate and anal area. The portfolio comprises four core SKUs: a paraffin-based protective ointment (the Nr. 1 recommendation), moisturizing vaginal ovules for vaginal dryness, a lipid-replenishing soap-free washing lotion, and a moisturizing intimate care cream. All products are dermatologically tested and built on formulations originally developed by founder Prof. Dr. Eiko E. Petersen.
Is kaymogyn a public or private company?
kaymogyn is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was kaymogyn founded?
kaymogyn was founded in 2002. It employs 11 to 50 people.
Where is kaymogyn based?
kaymogyn is headquartered in Berlin, Germany, in the Europe region.
How does kaymogyn make money?
One revenue line is on record: pharmacy Distribution Sales.
Who are kaymogyn's main competitors?
Direct peers on record are Vagisan, Multi-Gyn and Gynofit. Broad incumbents are Dr. Wolff Group, Eucerin (Beiersdorf), La Roche-Posay (L'Oréal), Linola (Dr. Wolff), CeraVe (L'Oréal) and Dermapharm Holding SE. Vagisil (Combe Incorporated) is listed as a regional player.
Does kaymogyn have an API?
No public API is recorded for kaymogyn.
What industry is kaymogyn in?
kaymogyn's product category is Medical Intimate Care Products. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of CRABAIAI, Vaginal Moisturizers & Lubricants. Its NAICS code is 325620 and its SIC code is 2844.